DWM
ABMD

Destination Wealth Management’s Abiomed Inc ABMD Stock Holding History

Destination Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-777
Closed -$257K – 209
2022
Q1 		$257K Hold
777
– – 0.01% 181
2021
Q4 		$279K Hold
777
– – 0.01% 177
2021
Q3 		$253K Hold
777
– – 0.01% 163
2021
Q2 		$243K Hold
777
– – 0.01% 172
2021
Q1 		$248K Sell
777
-100
-11% -$32K 0.01% 166
2020
Q4 		$284K Hold
877
– – 0.01% 146
2020
Q3 		$243K Buy
877
+10
+1% +$2.88K 0.01% 134
2020
Q2 		$209K Buy
+867
New +$174K 0.01% 142

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Destination Wealth Management's ABMD Position: Q2 2022 in Review

Destination Wealth Management sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 777 shares — an estimated $257K sold.

Destination Wealth Management first reported a position in ABMD in Q2 2020 and held it in 8 quarters. The position peaked at $284K in Q4 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Destination Wealth Management reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Destination Wealth Management sold 777 Abiomed Inc shares in Q2 2022, an estimated $257K.
  • Destination Wealth Management first reported a position in Abiomed Inc in Q2 2020 and held it in 8 quarters.
  • Destination Wealth Management's Abiomed Inc position peaked at $284K in Q4 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Destination Wealth Management's 13F filing for Q2 2022, filed 29 Jul 2022.